The infection of mouse by Theiler's virus: From genetics to immunology

Immunological Reviews

Volumn 159, Issue , 1997, Pages 163-176

  Monteyne, Philippe ^a   Bureau, Jean Francois ^a   Brahic, Michel ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; B LYMPHOCYTE; DEMYELINATION; DISEASE PREDISPOSITION; GENE LOCUS; GENE MUTATION; GENOME; H2 SYSTEM; IMMUNOGENETICS; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NATURAL KILLER CELL; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS RESISTANCE;

EID: 0030666492     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1997.tb01014.x     Document Type: Review

References (121)

1. Theiler M. Spontaneous encephalomyelitis of mice: a new virus disease. Science 1934;80:122-123.
2. Theiler M. Spontaneous encephalomyelitis of mice, a new virus disease. J Exp Med 1937;55:705-719.
3. Theiler M, Gard S. Encephalomyelitis of mice: I. Characteristics and pathogenesis of the virus. J Exp Med 1940;72:49-67.
4. Daniels JB, Pappenheimer AM, Richardson S. Observations on encephalomyelitis of mice (DA strain). J Exp Med 1952;96:22-24.
5. Lipton HL. Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect Immun 1975;11:1147-1155.
6. Dal Canto MC, Lipton HL. Multiple sclerosis: animal model of human disease. Theiler's virus infection in mice. Am J Pathol 1977;88:497-500.
7. Ozden S, Tangy F, Chamorro M, Brahic M. Theiler's virus genome is closely related to that of encephalomyocarditis virus, the prototype cardiovirus. J Virol 1986;60:1163-1165.
8. Pevear DC, Calenoff M, Rozhon E, Lipton HL. Analysis of the complete nucleotide sequence of the picornavirus Theiler's murine encephalomyelitis virus indicates that it is closely related to cardioviruses. J Virol 1987;61:1507-1516.
9. Ohara Y, Stein S, Fu J, Stillman L, Klaman L, Roos RP. Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis viruses. Virology 1988;164:245-255.
10. Pevear DC, Borkowski J, Calenoff M, Oh CK, Ostrowski B, Lipton HL. Insights into Theiler's virus neurovirulence based on a genomic comparison of the neurovirulent GDVII and less virulent BeAn strains. Virology 1988;165:1-12.
11. Kong WP, Ghadge GD, Roos RP. Involvement of cardiovirus leader in host cell-restricted virus expression. Proc Natl Acad Sci USA 1994;91:1796-1800.
12. Kong NP, Roos RP. Alternative translation initiation site in the DA strain of Theiler's murine encephalomyelitis virus. J Virol 1991;65:3395-3399.
13. Grant RA, Filman DJ, Fujinami RS, Icenogle JP, Hogle JM. Three-dimensional structure of Theiler's virus. Proc Natl Acad Sci USA 1992;89:2061-2065.
14. Luo M, He C, Toth KS, Zhang CX, Lipton HL. Three-dimensional structure of Theiler murine encephalomyelitis virus (BeAn strain). Proc Natl Acad Sci USA 1992;89:2409-2413.
15. Wada Y, Fujinami RS. Viral infection and dissemination through the olfactory pathway and the limbic system by Theiler's virus. Am J Pathol 1993;143:221-229.
16. Ha-Lee YM, et al. Mode of spread to and within the central nervous system after oral infection of neonatal mice with the DA strain of Theiler's murine encephalomyelitis. J Virol 1995;69:7354-7361.
17. Michiels T, Jarousse N, Brahic M. Analysis of the leader and capsid coding regions of persistent and neurovirulent strains of Theiler's virus. Virology 1995;214:550-558.
18. Lipton HL. Persistent Theiler's murine encephalomyelitis virus infection in mice depends on plaque size. J Gen Virol 1980;46:169-177.
19. McAllister A, Tangy F, Aubert C, Brahic M. Genetic mapping of the ability of Theiler's virus to persist and demyelinate [published erratum appears in J Virol 1993;67:2427]. J Virol 1990;64:4252-4257.
20. Tangy F, McAllister A, Aubert C, Brahic M. Determinants of persistence and demyelination of the DA strain of Theiler's virus are found only in the VP1 gene [published erratum appears in J Virol 1993;67:2427]. J Virol 1991;65:1616-1618.
21. Jarousse N, et al. Chimeric Theiler's virus with altered tropism for the central nervous system. J Virol 1994;68:2781-2786.
22. Brahic M, Stroop WG, Baringer JR. Theiler's virus persists in glial cells during demyelinating disease. Cell 1981;26:123-128.
23. Aubert C, Chamorro M, Brahic M. Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease. Microb Pathog 1987;3:319-326.
24. Rodriguez M, Leibowitz JL, Lampert PW. Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann Neurol 1983;13:426-433.
25. Lipton HL, Twaddle G, Jelachich ML. The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Virol 1995;69:2525-2533.
26. Pena Rossi C, et al. Role of macrophages during Theiler's virus infection. J Virol 1997;71:3336-3340.
27. Cash E, Chamorro M, Brahic M. Theiler's virus RNA and protein synthesis in the Central Nervous System of demyelinating mice. Virology 1985;144:290-294.
28. Cash E, Chamorro M, Brahic M. Minus-strand RNA synthesis in the spinal cords of mice persistently infected with Theiler's virus. J Virol 1988;62:1824-1826.
29. Jelachich ML, Bandyopadhyay P, Blum K, Lipton HL. Theiler's virus growth in murine macrophage cell lines depends on the state of differentiation. Virology 1995;209:437-444.
30. Ozden S, Aubert C, Gonzalez-Dunia D, Brahic M. In situ analysis of proteolipid protein gene transcripts during persistent Theiler's virus infection. J Histochem Cytochem 1991;39: 1305-1309.
31. Ozden S, Aubert C, Bureau JF, Gonzalez-Dunia D, Brahic M. Analysis of proteolipid protein and Po transcripts in different mice infected with Theiler's virus. Microb Pathog 1993;14:123-131.
32. Lipton HL, Dal Canto MC. Chronic neurologic disease in Theiler's virus infection of SJL/J mice. J Neurol Sci 1976;30:201-207.
33. Lipton HL, Dal Canto MC. Susceptibility of inbred mice to chronic central nervous system infection by Theiler's murine encephalomyelitis virus. Infect Immun 1979;26:369-374.
34. Lipton HL, Melvold RW. Genetic analysis of susceptibility to Theiler's virus-induced demyelinating disease in mice. J Immunol 1984;132:1821-1825.
35. Rodriguez M, David CS. Demyelination induced by Theiler's virus: influence of the H-2 haplotype. J Immunol 1985;135:2145-2148.
36. Clatch RJ, Melvold RW, Miller SD, Lipton HL. Theiler's murine encephalomyelitis virus (TMEV) induced demyelinating disease in mice is influenced by the H-2D region: correlation with TMEV specific delayed-type hypersensitivity. J Immunol 1985;135:1408-1413.
37. Rodriguez M, Leibowitz JL, David CS. Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region. J Exp Med 1986;163:620-631.
38. Patick AK, Pease LR, David CS, Rodriguez M. Major histocompatibility complex-conferred resistance to Theiler's virus-induced demyelinating disease is inherited as a dominant trait in B10 congenic mice. J Virol 1990;64:5570-5576.
39. Bureau JF, Montagutelli X, Lefebvre S, Guénet J-L, Pla M, Brahic M. The interaction of two groups of murine genes controls the persistence of Theiler's virus in the central nervous system. J Virol 1992;66:4698-4704.
40. b gene become resistant to persistent infection by Theiler's virus. J Virol 1994;68:4049-4052.
41. d transgene suppresses Theiler's virus-induced demyelination in susceptible strains of mice. J Neurovirol 1995;1:111-117.
42. Lipton HL, Melvold R, Miller SD, Dal Canto MC. Mutation of a major histocompatibility class I locus, H-2D, leads to an increased virus burden and disease susceptibility in Theiler's virus-induced demyelinating disease. J Neurovirol 1995;1:138-144.
43. Lindsley MD, Rodriguez M. Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus. J Immunol 1989;142:2677-2682.
44. + T cells in the acute and chronic phases of Theiler's murine encephalomyelitis virus-induced disease in mice. J Gen Virol 1992;73:1861-1865.
45. Fiette L, Aubert C, Brahic M, Pena Rossi C. Theiler's virus infection of β2-microglobulin-deficient mice. J Virol 1993;67:589-592.
46. b mice deficient in β2-microglobulin. J Immunol 1993;151:255-276.
47. Pullen LC, Miller SD, Dal Canto MC, Kim ES. Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelmation. Eur J Immunol 1993;23:2287-2293.
48. + T lymphocytes provide protection against TMEV-induced demyelinating disease in BALB/c mice. J Immunol 1996;156:1276-1283.
49. Pena Rossi C, McAllister A, Fiette L, Brahic M. Theiler's virus infection induces a specific cytotoxic T lymphocyte response. Cell Immunol 1991;138:341-348.
50. Lindsley MD, Thiemann R, Rodriguez M. Cytotoxic T cells isolated from the Central Nervous System of mice infected with Theiler's virus. J Virol 1991;65:6612-6620.
51. Larsson-Sciard EL, Dethlefs S, Brahic M. In vivo administration of Interleukin-2 protects susceptible mice from Theiler's virus persistence. J Virol 1997;71:797-799.
52. Dethlefs S, Escriou N, Brahic M, van der Werf S, Larsson-Sciard EL. Theiler's virus and Mengo virus induce cross-reactive cytotoxic T lymphocytes restricted to the same immunodominant VP2 epitope in C57BL/6 mice. J Virol 1997;71:5361-5365.
53. Altintas A, Cai Z, Pease LR, Rodriguez M. Differential expression of H-2K and H-2D in the central nervous system of mice infected with Theiler's virus. J Immunol 1993;151:2803-2812.
54. Lin X, Pease LR, Rodriguez M. Differential generation of class I H-2D- versus H-2K-restricted cytotoxicity against a demyelinating virus following central nervous system infection. Eur J Immunol 1997;27:963-970.
55. Melvold RW, Jokinen DM, Knobler RL, Lipton HL. Variations in genetic control of susceptibility to Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease I. Differences between susceptible SJL/J and resistant BALB/c strains map near the T cell β-chain constant gene on chromosome 6. J Immunol 1987;138:1429-1433.
56. Melvold RW, Jokinen DM, Miller SD, Dal Canto MC, Lipton HL. Identification of a locus on mouse chromosome-3 involved in differential susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Virol 1990;64:686-690.
57. Neumann PE. Two-locus linkage analysis using recombinant inbred strains and Bayes' theorem. Genetics 1990;126:277-284.
58. Dietrich WF, et al. A genetic map of the mouse with 4006 simple sequence length polymorphisms. Nat Genet 1994;7:220-225.
59. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994;265:2037-2048.
60. Fijneman RJA, de Vries SS, Jansen RC, Demant P. Complex interactions of new quantitative trait loci, Sluc1, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse. Nat Genet 1996;14:465-467.
61. van Wezel T, Stassen APM, Moen CJA, Hart AAM, van der Valk MA, Demant P. Gene interaction and single gene effects in colon tumour susceptibility in mice. Nat Genet 1996;14:468-473.
62. Kappel CA, Dal Canto MC, Melvold RW, Kim BS. Hierarchy of effects of the MHC and T cell receptor β-chain genes in susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Immunol 1991;147:4322-4326.
63. Bahk YY, Kappel CA, Rasmussen G, Kim BS. Association between susceptibility to Theiler's virus-induced demyelination anti T-cell receptor Jβ1-Cβ1 polymorphism rather than Vβ deletion. J Virol 1997;71:4181-4185.
64. Rodriguez M, Patick AK, Pease LR, David CS. Role of T cell receptor Vβ genes in Theiler's virus-induced demyelination of mice. J Immunol 1992;148:921-927.
65. Rodriguez M, Nabozny GH, Thiemann RL, David CS. Influence of deletion of T cell receptor-beta genes on Theiler's virus. Autoimmunity 1994;19:221-230.
66. Rodriguez M, Prayoonwiwat N, Zhou P, David C. Expression of T cell receptor Vβ transcripts in central nervous system of mice susceptible and resistant to Theiler's virus-induced demyelination. J Neuroimmunol 1993;47:95-100.
67. Musette P, Bureau JF, Gachelin G, Kourilsky P, Brahic M. T lymphocyte repertoire in Theiler's virus encephalomyelitis: the nonspecific infiltration of the central nervous system of infected SJL/J mice is associated with a selective local T cell expansion. Eur J Immunol 1995;25:1589-1593.
68. Bureau JF, Montagutelli X, Bihl F, Lefebvre S, Guénet JL, Brahic M. Mapping loci influencing the persistence of Theiler's virus in the murine central nervous system. Nat Genet 1993;5:87-91.
69. Pullen LC, Miller SD, Dal Canto MC, Van der Meide PH, Kim BS. Alteration in the level of interferon-γ results in acceleration of Theiler's virus-induced demyelinating disease. J Neuroimmunol 1994;55:143-152.
70. Fiette L, et al. Theiler's virus infection of 129Sv mice that lack the inferferon α/β or interferon γ receptors. J Exp Med 1995;181:2069-2076.
71. Rodriguez M, Pavelko K, Coffman RL. Gamma interferon is critical for resistance to Theiler's virus-induced demyelination. J Virol 1995;69:7286-7290.
72. Rubio N, Torres C. IL-1, IL-2 and IFN gamma production by Theiler's virus-induced encephalomyelitic SJL/J mice. Immunology 1991;74:284-289.
73. Kohanawa M, Nakane A, Minagawa T. Endogenous gamma interferon produced in the central nervous system by systemic infection with Theiler's virus in mice. J Neuroimmunol 1993;48:205-212.
74. Mokhtarian F, Shi Y, Zhu P-S, Grob D. Immune responses, and autoimmune outcome, during virus infection of the central nervous system. Cell Immunol 1994;157:195-210.
75. Billiau A. Interferon-γ: biology and role in pathogenesis. Adv Immunol 1996;62:61-130.
76. Guidotti LG, Chisari FV. To kill or to cure: options in host defense against viral infection. Curr Opin Immunol 1996;8:478-483.
77. Kaminsky SG, Milisauskas V, Chen PB, Nakamura I. Defective differentiation of natural killer cells in SJL mice. Role of the thymus. J Immunol 1987;138:1020-1025.
78. Kaminsky SG, Nakamura I, Cudkowicz G. Genetic control of the natural killer cell activity in SJL and other strains of mice. J Immunol 1985;135:665-671.
79. Paya CV, Patick AK, Leibson PJ, Rodriguez M. Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus. J Immunol 1989;143:95-102.
80. + T cells as novel interleukin-12 responsive killer T cell precursors. Jpn J Cancer Res 1996;87:429-432.
81. Welsh CJR, Tonks P, Nash AA, Blakemore WF. The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice. J Gen Virol 1987;68:1659-1667.
82. Rodriguez M, Lindsley MD, Pierce ML. Role of T cells in resistance to Theiler's virus infection. Microb Pathog 1991;11:269-281.
83. + T cells contribute to protection in Theiler's murine encephalomyelitis. Immunology 1993;80:502-506.
84. Miller SD, Clatch RJ, Pevear DC, Lipton HL. Class II-restricted T cell responses in Theiler's murine encephalomyelilis virus-induced demyelinating disease. I. Cross-specificity among TMEV substrains and related picornaviruses, but not myelin proteins. J Immunol 1987;138:3776-3784.
85. Miller S, Gerety S. Immunologic aspects of Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. Semin Virol 1990;1:263-272.
86. Gerety SJ, Clatch RJ, Lipton HL, Goswami RG, Rundell MK, Miller SD. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. IV. Identification of an immunodominant T cell determinant on the N-Terminal end of the VP2 capsid protein in susceptible SJL/J mice. J Immunol 1991;146:2401-2408.
87. Gerety SJ, et al. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice. J Immunol 1994;152:908-918.
88. Karpus WJ, Pope JG, Peterson JD, Dal Canto MC, Miller SD. Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction. J Immunol 1995;155:947-957.
89. + T cell line specific for an immunodominant VP2 epitope. J Immunol 1994;152:919-929.
90. + T cell-mediated pathology. J Immunol 1996;156:4050-4058.
91. Njenga MK, et al. Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice. J Virol 1996;70:1729-1737.
92. Fiette L, Brahic M, Pena Rossi C. The infection of class II-deficient mice by the DA strain of Theiler's virus. J Virol 1996;70:4811-4815.
93. Cosgrove D, et al. Mice lacking MCH Class II molecules. Cell 1991;66:1051-1066.
94. Roos RP, Wollmann R. DA strain of Theiler's murine encephalomyelitis virus induces demyelination in nude mice. Ann Neurol 1984;15:494-499.
95. Rosenthal A, Fujinami RS, Lampert PW. Mechanism of Theiler's virus induced demyelination in nude mice. Lab Invest 1986;54:515-522.
96. Zurbriggen A, Fujinami RS. Theiler's virus infection in nude mice: Viral RNA in vascular endothelial cell. J Virol 1988;62:3589-3596.
97. + T cells. Annu Rev Immunol 1994;12:635-673.
98. Coutelier JP, Van der Logt JTM, Heessen FWA, Warnier G, Van Snick J. IgG2a restriction of murine antibodies elicited by viral infections J Exp Med 1987;165:64-69.
99. Coutelier JP, van der Logt JTM, Heessen FWA, Vink A, Van Snick J. Virally-induced modulation of murine IgG antibody subclasses. J Exp Med 1988;168:2373-2378.
100. Monteyne P, Van Broeck J, Van Snick J, Coutelier J-P. Inhibition by lactate dehydrogenase-elevating virus of in vivo interleukin-4 production during immunization with keyhole limpet haemocyanin. Cytokine 1993;5:394-397.
101. Lipton HL, Gonzalez-Scarano F. Central Nervous System immunity in mice infected with Theiler's virus I. Local neutralizing antibody response. J Infect Dis 1978;137:145-155.
102. Clatch RJ, Pevear DC, Rozhon E, Roos RP, Miller SD, Lipton HL. Characterization and specificity of humoral immune responses to Theiler's murine encephalomyelitis virus capsid proteins. J Gen Virol 1987;68:3191-3196.
103. Fujinami RS, Zurbriggen A, Powell HC. Monoclonal antibody defines determinant between Theiler's virus and lipid-like structures. J Neuroimmunol 1988;20:25-32.
104. Zurbriggen A, Hogle JM, Fujinami RS. Alteration of amino acid 101 within capsid protein VP1 changes the pathogenicity of Theiler's murine encephalomyelitis virus. J Exp Med 1989;170:2037-2049.
105. Zurbriggen A, Thomas C, Yamada M, Roos RP, Fujinami RS. Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection. J Virol 1991;65:1929-1937.
106. Crane MA, Jue C, Mitchell M, Lipton H, Kim BS. Detection of restricted predominant epitopes of Theiler's murine encephalomyelitis virus capsid proteins expressed in the lambda gt11 system: differential patterns of antibody reactivity among different mouse strains. J Neuroimmunol 1990;27:173-186.
107. Kim BS, Choe YK, Crane MA, Jue CR. Identification and localization of a limited number of predominant conformation-independent antibody epitopes of Theiler's murine encephalomyelitis virus. Immunol Lett 1992;31:199-205.
108. Inoue A, Choe YK, Kim BS. Analysis of antibody responses to predominant linear epitopes of Theiler's murine encephalomyelitis virus. J Virol 1994;68:3324-3333.
109. Johnston IC, Usherwood EJ, Nash AA, Brown TD. Theiler's murine encephalomyelitis virus 3D RNA polymerase: its expression in the CNS and the specific immune response generated in persistently infected mice. J Gen Virol 1995;76:2765-2777.
110. Fujinami RS, Rosenthal A, Lampert PW, Zurbriggen A, Yamada M. Survival of athymic (nu/nu) mice after Theiler's murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody. J Virol 1989;63:2081-2087.
111. Rodriguez M, Kenny JJ, Thiemann RL, Woloschak GE. Theiler's virus-induced demyelination in mice immunosuppressed with anti-IgM and in mice expressing the xid gene. Microb Pathog 1990;8:23-35.
112. Pena Rossi C, Cash E, Aubert C, Coutinho A. Role of the humoral immune response in resistance to Theiler's virus infection. J Virol 1991;65:3895-3899.
113. Kurtz CI, Sun XM, Fujinami RS. B-lymphocyte requirement for vaccine-mediated protection from Theiler's murine encephalomyelitis virus-induced central nervous system disease. J Virol 1995;69:5152-5155.
114. Kurtz CI, Sun XM, Fujinami RS. Protection of SJL/J mice from demyelinating disease mediated by Theiler's murine encephalomyelitis virus. Microb Pathog 1995;18:11-27.
115. Cash E, Bandeira A, Chirinian S, Brahic M. Characterization of B lymphocytes present in the demyelinating lesions induced by Theiler's virus. J Immunol 1989;143:984-988.
116. Peterson JD, Waltenbaugh C, Miller SD. IgG subclass responses to Theiler's murine encephalomyelitis virus infection and immunization suggest a dominant role for Th1 cells in susceptible mouse strains. Immunology 1992;75:652-658.
117. Peterson JD, Karpus WJ, Clatch RJ, Miller SD. Split tolerance of Th1 and Th2 cells in tolerance to Theiler's murine encephalomyelitis virus. Eur J Immunol 1993;23:46-55.
118. h2 cytokine responses. Int Immunol 1994;6:721-730.
119. Palma JP, Park SH, Kim BS. Treatment with lipopolysaccharide enhances the pathogenicity of a low-pathogenic variant of Theiler's murine encephalomyelitis virus. J Neurosci Res 1996;45:776-785.
120. Bihl F, Pena Rossi C, Guénet JL, Brahic M, Bureau JF. The shiverer mutation affects the persistence of Theiler's virus in the central nervous system. J Virol 1997;71:5025-5030.
121. Tienari PJ, Wikström J, Sajantila A, Palo J, Peltonen L. Genetic susceptibility to multiple sclerosis linked to myelin basic protein. Lancet 1992;340:987-991.